Sep 01 ,2023
Synopsis
European equity markets are set to open mostly flat to marginally higher as a new month of trading gets under way. In August, the Stoxx Europe 600 fell (2.79%), snapping a two month winning streak.
Asian equities mixed Friday Japan equities outperforming though quiet elsewhere with mainland China and Korea little changed. ASX underperforming region. Hang Seng and Philippines markets shut due to typhoon. S&P 500 futures steady afterhours. Treasury curve bear flattening ahead of US nonfarm payrolls. Yuan erased gains that following PBOC FX RRR cut. Base metals leading commodity market gains as crude hovers near three-week high.
Macro data releases out today in Europe include Norway/Spain/Sweden/Switzerland Aug manufacturing PMI and final reads for Eurozone/France/Germany/UK, Switzerland Aug CPI, Italy/Ireland/Austria Q2 final GDP, Italy Jul PPI, Austria Aug unemployment rate, UK Aug house price index - Nationwide.
Macro/politics
China ramps up economic support as Country Garden vote looms - Reuters
New ECB Inflation Outlook to Be Similar to June, Guindos Says - BBG
Two Million Britons Are Using Buy-Now-Pay-Later for Essentials - BBG
British home prices to fall 4% in 2023 as borrowing costs bite: Reuters poll
Swedish Home Buyers Cancel Bookings on New Houses at Record Rate - BBG
Top company news
Earnings/updates
NDA.GR (Aurubis) -- identifies serious indications of shortfall in metals during a scheduled review of inventories
FIE.GR (Fielmann Group) -- closes US acquisition of SVS Vision, upgrades FY2023 prognosis
CFT.SW (Cie Financiere Tradition) -- reports H1 EPS CHF6.93 vs year-ago CHF6.78
M&A
HSBA.LN (HSBC Holdings) -- Pepper Money to acquire HSBC's mortgage portfolio in New Zealand; terms undisclosed
BNP.FP (BNP Paribas) -- Mirae Asset Financial Group looking at buying Sharekhan - Korea Economic Daily
Healthcare
ROG.SW (Roche Holding) -- Roche's Alecensa delivers unprecedented Phase III results for people with ALK-positive early-stage lung cancer
BAYN.GR (Bayer AG) -- Bayer expands clinical development program investigating finerenone for potential treatment of heart failure
BAYN.GR (Bayer AG) -- Bayer's Kerendia (finerenone) included in latest focused guideline clinical updates from European Society of Cardiology
IPN.FP (Ipsen) -- Ipsen, EVP and Head of R&D, Howard Mayer, who will leave on 22-Sep, following his decision to retire.
Other
BMW.GR (Bayerische Motoren Werke) -- BMW considers political requirement to abandon combustion engine to be negligent - Handelsblatt
VWS.DC (Vestas Wind Systems) -- signs conditional agreement for onshore wind power project above 1 GW in the USA
BA.LN (BAE Systems) -- awarded $432.6M U.S. Army contract modifcation
BA.LN (BAE Systems) -- awarded $274.1M U.S. Army contract
BA.LN (BAE Systems) -- awarded $100.9M U.S. Defense contract modification
BA.LN (BAE Systems) -- awarded $432.6M US Army contract modification
TIGO.SS (Millicom International Cellular) -- announces resignation of Chairman José Antonio Ríos García; appoint CEO Mauricio Ramos as Interim Chairman through 2024 AGM; disclose additional executive appointments and CEO succession plan
QQ.LN (QinetiQ Group) -- announces $224M contract win in the US
AF.FP (Air France-KLM) -- finalizes split of Air France - KLM shares and capital reduction as announced on 31-July-2023
Duke Energy CIO says AI can accelerate energy transformation
Key rating changes
Upgrades
Morgan Stanley upgrades EQNR.NO, GALP.PL, REP.SM
Downgrades
VOW3.GR (Volkswagen) -- to sell from neutral at UBS
RNO.FP (Renault) -- to sell from neutral at UBS
Initiations
GBLB.BB (Groupe Bruxelles Lambert) -- initiated buy with €86 target at Kepler Cheuvreux
SOF.BB (Sofina) -- initiated buy with €261 target at Kepler Cheuvreux
Data
Nikkei +0.45% to 32764.88
Hang Seng +0.00% to 18382.06
Shanghai Composite +0.23% to 3126.99
S&P futures +5.3 vs prior close of 4516.0
€-$ +0.0001 or +0.01% to 1.0846
$-¥ +0.04 or +0.03% to 145.58
€-¥ +0.08 or +0.05% to 157.88
This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".
DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE